2-amino-3-methylimidazo(4,5-f)quinoline has been researched along with bromodeoxyuridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, S; Makino, S; Mori, S; Morimura, K; Nomura, T; Salim, EI; Wanibuchi, H; Yamamoto, S | 1 |
| Dashwood, RH; Horio, DT; Orner, GA; Xu, M | 1 |
| Hirose, M; Ishii, Y; Kanki, K; Kitamura, Y; Kuroiwa, Y; Masegi, T; Nishikawa, A; Umemura, T | 1 |
3 other study(ies) available for 2-amino-3-methylimidazo(4,5-f)quinoline and bromodeoxyuridine
| Article | Year |
|---|---|
Low-dose-dependent carcinogenic potential of 2-amino-3-methylimidazo[4,5-f]quinoline in the immunodeficient (SCID) mouse colon.
Topics: Animals; Body Weight; Bromodeoxyuridine; Carcinogens; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Immunohistochemistry; Kidney; Liver; Male; Mice; Mice, SCID; Organ Size; Quinolines; Severe Combined Immunodeficiency | 1999 |
Colonic cell proliferation, apoptosis and aberrant crypt foci development in rats given 2-amino-3-methylimidaz.
Topics: Administration, Oral; Animals; Antimetabolites; Apoptosis; Bromodeoxyuridine; Carcinogens; Cell Division; Cell Transformation, Neoplastic; Chemoprevention; Chlorophyllides; Colonic Neoplasms; Dose-Response Relationship, Drug; Homeostasis; Male; Neoplasms, Experimental; Quinolines; Rats; Rats, Inbred F344 | 2001 |
Lung as a new target in rats of 2-amino-3-methylimidazo[4,5-f]quinoline carcinogenesis: results of a two-stage model initiated with N-bis(2-hydroxypropyl)nitrosamine.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Bromodeoxyuridine; Carcinogens; Cell Proliferation; Disease Models, Animal; DNA; DNA Damage; Guanine; Lipid Peroxidation; Lung; Lung Neoplasms; Male; Nitrosamines; Oxidative Stress; Quinolines; Rats; Thiobarbituric Acid Reactive Substances | 2006 |